General Info

I am an endocrinologist with particular interest in bone metabolism in people with cancer. I see both patients with benign metabolic bone diseases, such as osteoporosis and hyperparathyroidism, and bone disorders due to advanced cancer, such as hypercalcemia of malignancy and metastatic bone disease. Much of my research has focused on rare complications of a subset of bone protective drugs known as antiresorptives. I have twice served on the National Comprehensive Cancer Care Network’s Bone Health in Cancer Care task force.